Carole de Picciotto 1, Coraline Duménil 2, Olivier Auzel 3, Violaine Giraud 2 and Marcel Bonay 1,4,5*

Similar documents
Monitoring: gas exchange, poly(somno)graphy or device in-built software?

Policy Specific Section: October 1, 2010 January 21, 2013

BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT

Identification and Treatment of the Patient with Sleep Related Hypoventilation

Average volume-assured pressure support

Chronic NIV in heart failure patients: ASV, NIV and CPAP

(To be filled by the treating physician)

2/13/2018 OBESITY HYPOVENTILATION SYNDROME

Worsening Hypoxemia in the Face of Increasing PEEP: A Case of Large Pulmonary Embolism in the Setting of Intracardiac Shunt

Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients

Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.

Objectives. Health care significance of ARF 9/10/15 TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION

A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation

Hypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment

RESPIRATORY FAILURE. Dr Graeme McCauley KGH

NON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018

Sleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016

Challenging Cases in Pediatric Polysomnography. Fauziya Hassan, MBBS, MS Assistant Professor Pediatric Pulmonary and Sleep

NIPPV FOR THE HYPERCAPNIC COPD AND OBSESITY HYPOVENTILATION PATIENT

Case Report Sinus Venosus Atrial Septal Defect as a Cause of Palpitations and Dyspnea in an Adult: A Diagnostic Imaging Challenge

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome

Supplementary Online Content

BiLevel Pressure Device

NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity

What is the next best step?

Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

November 2012 Critical Care Case of the Month: I Just Can t Do It Captain! I Can t Get the Sats Up!

11/20/2015. Beyond CPAP. No relevant financial conflicts of interest. Kristie R Ross, M.D. November 12, Describe advanced ventilation options

ONLINE DATA SUPPLEMENT. Impact of Obstructive Sleep Apnea on Left Ventricular Mass and. Diastolic Function

Recent Advances in Respiratory Medicine

Respiratory Pathophysiology Cases Linda Costanzo Ph.D.

OSA and COPD: What happens when the two OVERLAP?

APRV Ventilation Mode

Case 1. Level of difficulty: 2/5

Albert L. Rafanan, MD; Joseph A. Golish, MD, FCCP; Dudley S. Dinner, MD; L. Kathleen Hague, RN; and Alejandro C. Arroliga, MD, FCCP

Cor pulmonale. Dr hamid reza javadi

Chapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension

Reasons Providers Use Bilevel

Chronic Obstructive Pulmonary Disease

Home Pulse Oximetry for Infants and Children

1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.

Respiratory Complications of Obesity. Diana Wilson, M.D. ACP Educational Session September 16, 2017

Transcutaneous Monitoring and Case Studies

Introduction and Overview of Acute Respiratory Failure

All About Positive Airway Pressure (PAP) Therapy

CAPNOGRAPHY in the SLEEP CENTER Julie DeWitte, RCP, RPSGT, RST Assistant Department Administrator Kaiser Permanente Fontana Sleep Center

In-Patient Sleep Testing/Management Boaz Markewitz, MD

1.1.2 CPAP therapy is used for patients who are suffering from an acute type 1 respiratory failure (Pa02 <8kPa with a normal or low Pac02).

PEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA)

An 85-year-old woman with respiratory failure and positional hypoxemia

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the Edwards PreSep oximetry catheter

Indications for Respiratory Assistance. Sheba Medical Center, ICU Department Nick D Ardenne St George s University of London Tel Hashomer

Auto Servo Ventilation Indications, Basics of Algorithm, and Titration

Sleep Disordered Breathing: Beware Snoring! Dr T A McDonagh Consultant Cardiologist Royal Brompton Hospital London. UK

OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV. J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain

5. What is the cause of this patient s metabolic acidosis? LACTIC ACIDOSIS SECONDARY TO ANEMIC HYPOXIA (HIGH CO LEVEL)

CASE REPORT. Miyuki Okuda 1*, Makoto Kashio 1, Nobuya Tanaka 1, Takashi Fujii 1 and Yoshinari Okuda 2

Mario Kinsella MD FAASM 10/5/2016

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

Capnography Connections Guide

Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia

Long-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study

By Mark Bachand, RRT-NPS, RPFT. I have no actual or potential conflict of interest in relation to this presentation.

SLEEP DISORDERED BREATHING AND CHRONIC LUNG DISEASE: UPDATE ON OVERLAP SYNDROMES

Choosing the Appropriate Mode of PAP Therapy in the Perioperative Setting

2/4/2011. Nathan Kerner, M.D.

Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study

Non-Invasive Ventilation

Acute Respiratory Distress Syndrome (ARDS) An Update

NON INVASIVE LIFE SAVERS. Non Invasive Ventilation (NIV)

Hepatopulmonary Syndrome: An Update

Obstructive sleep apnea (OSA) is the periodic reduction

Causes and Consequences of Respiratory Centre Depression and Hypoventilation

NIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH

Anesthetic Challenges in Morbid Obesity

Respiratory Assist Device E0470:

RESPIRATORY ASSIST DEVICE E0470

Adult Echocardiography Examination Content Outline

Apnea-Hypopnea- Index The new old biomarker for Sleep-Disordered Breathing. Alan S Maisel MD

Physiological Causes of Abnormal ABG s

POLICY. Number: Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE. Authorization

Martin R Cowie Professor of Cardiology, National Heart & Lung Institute Imperial College London (Royal Brompton Hospital)

Polysomnography (PSG) (Sleep Studies), Sleep Center

Triennial Pulmonary Workshop 2012

Capnography. Capnography. Oxygenation. Pulmonary Physiology 4/15/2018. non invasive monitor for ventilation. Edward C. Adlesic, DMD.

How To Set Up A Ven.lator: Standard Versus High Pressure

How to write bipap settings

Best Match. Non-Invasive Ventilation. WSS Fall Objectives. BiPAP AVAPS Patient Types 9/10/2018. Advanced Algorithms - Clinical Applications

OXYGEN USE IN PHYSICAL THERAPY PRACTICE. Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR

Objectives. Apnea Definition and Pitfalls. Pathophysiology of Apnea. Apnea of Prematurity and hypoxemia episodes 5/18/2015

The Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS)

Interpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow

RESEARCH PACKET DENTAL SLEEP MEDICINE

Echocardiography Conference

NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)

Sample Case Study. The patient was a 77-year-old female who arrived to the emergency room on

WRHA Surgery Program. Obstructive Sleep Apnea (OSA)

Tissue is the Issue. PEEP CPAP FiO2 HFNC PSV HFNC. DO 2 = CO [(Hb x 1.34) SaO PaO 2 ] perfusione

Transcription:

de Picciotto et al. Journal of Medical Case Reports (2017) 11:234 DOI 10.1186/s13256-017-1393-1 CASE REPORT Open Access Paradoxical worsening of hypoxemia in a patient treated by noninvasive positive pressure ventilation for obesity hypoventilation syndrome with concomitant obstructive sleep apnea: a case report Carole de Picciotto 1, Coraline Duménil 2, Olivier Auzel 3, Violaine Giraud 2 and Marcel Bonay 1,4,5* Abstract Background: Noninvasive positive pressure ventilation is frequently prescribed to obese patients with obstructive sleep apnea syndrome and obesity hypoventilation syndrome. However, mechanical ventilation with a positive end-expiratory pressure can induce or worsen a right-to-left shunt through a patent foramen ovale associated with systemic hypoxemia. Thus, in obese patients treated with noninvasive positive pressure ventilation, a paradoxical worsening of hypoxemia may reveal the existence of a patent foramen ovale. Case presentation: A 50-year-old African woman was referred to our sleep center for severe obstructive sleep apnea syndrome and obesity hypoventilation syndrome. Because she had alveolar hypoventilation and had failed previous obstructive sleep apnea syndrome therapy, noninvasive positive pressure ventilation was started. In May 2015, she had a normal residual apnea/hypopnea index calculated by the ventilator software with no hypoventilation. Six months later, severe hypoxemia without hypercapnia was noted. Contrast transthoracic echocardiography showed right-to-left shunt through a patent foramen ovale. This finding prompted a decrease in expiratory and inspiratory positive airway pressures, after which the ventilator software recorded a normal residual apnea/hypopnea index and the blood gas values improved. Conclusion: Noninvasive positive pressure ventilation therapy for combined obstructive sleep apnea syndrome and obesity hypoventilation syndrome must be monitored by arterial blood gas measurements, both to reassess the hypercapnia and to look for worsening hypoxemia due to a patent foramen ovale. Keywords: Hypoxemia, Obstructive sleep apnea, Hypoventilation, Noninvasive ventilation, Obesity * Correspondence: marcel.bonay@inserm.fr 1 Service de Physiologie-Explorations Fonctionnelles, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France 4 Unité Inserm U1179, laboratoire de physiologie TITAN, UFR des Sciences de la Santé Simone Veil, Université de Versailles St Quentin (UVSQ), Montigny le Bretonneux, France Full list of author information is available at the end of the article The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

de Picciotto et al. Journal of Medical Case Reports (2017) 11:234 Page 2 of 5 Background The foramen ovale is a congenital opening between the two cardiac atria that usually closes shortly after birth but may remain patent. Thus, a patent foramen ovale (PFO) is found at autopsy in 20 to 34% of the general population [1]. The PFO represents a channel through which unidirectional blood flow from the right venous blood to the left oxygenated arterial system may occur. The passage of blood from the venous blood into the left arterial blood without lung oxygenation is named right-to-left shunt. It may be associated with hypoxemia, defined in terms of reduced oxygen pressure in the systemic arterial blood (PaO 2 ), as detected by an arterial blood gas (ABG) measurement at rest. Right atrial pressures are elevated in patients with pulmonary hypertension (PH), which may be primary or secondary to another condition such as chronic obstructive pulmonary disease (COPD) or obstructive sleep apnea syndrome (OSAS) [2], and enhance the chance of a right-to-left intracardiac shunt through the foramen ovale. Of 48 patients with OSAS, 33 (69%) had a PFO detectable by contrast transesophageal echocardiography (TEE), compared to only 4 (17%) of 24 controls (P < 0.0001) [3]. Systolic pulmonary artery pressure (spap) was significantly higher in the patients than in the controls. In the absence of right atrial pressure elevation, right-to-left shunt through the foramen ovale may occur intermittently, sometimes in relation to body position (platypnea-orthodeoxia syndrome). Right atrial pressures may rise abnormally in the absence of PH, for instance during mechanical ventilation with a positive endexpiratory pressure (PEEP) of at least 10 cm H 2 O. In this situation, right-to-left shunt through the PFO worsens the systemic hypoxemia [4 6]. Furthermore, a peak inspiratory airway pressure of 20 cm H 2 O has been shown to improve the TEE detection of PFO [7]. Finally, in a patient with tetralogy of Fallot and severe kyphoscoliosis, noninvasive ventilation paradoxically worsened the hypoxemia by increasing the right-to-left interventricular and right ventriculoatrial pressure gradients [8]. We are not aware of previous reports of paradoxical worsening of hypoxemia due to a right-to-left shunt through a PFO in a patient chronically treated by noninvasive positive pressure ventilation (NPPV) for obesity hypoventilation syndrome (OHS) with concomitant OSAS. Case presentation A 50-year-old African woman was referred to our sleep center for a combination of severe OSAS and OHS. She had a history of systemic hypertension treated since 2010, chronic systemic lupus erythematosus with cutaneous and joint manifestations, a positive serum anticardiolipin antibody test, and Sjögren s syndrome with lymphocytic interstitial lung disease diagnosed in 2009 and treated by an immunosuppressant and glucocorticoid until 2011. Her body mass index was 35.6 kg/m 2.Consequently,in January 2015, she underwent respiratory polygraphy (CID 102 L; Cidelec, Angers, France) to look for OSAS. Her apnea/hypopnea index (AHI) was 37/hour, indicating severe OSAS. Obstructive hypopneas predominated (Fig. 1a). Total lung capacity and forced expiratory volume in one second/vital capacity (FEV1/VC) were normal but singlebreath diffusing capacity of the lungs for carbon monoxide (DLCO) was slightly decreased. ABG analysis evidenced hypoxemia and chronic hypercapnia: PaO 2, 78 mmhg; carbon dioxide pressure in the systemic arterial blood (PaCO 2 ), 48 mmhg; ph, 7.39; calculated bicarbonate level, 29 mmol/l; and hemoglobin oxygen saturation, 94%. The combination of obesity and alveolar hypoventilation in the absence of lung or neuromuscular disease established the diagnosis of OHS. She had previously discontinued continuous positive airway pressure (CPAP) therapy due to discomfort with a feeling of suffocation. Given the alveolar hypoventilation, she was therefore started on NPPV (S9 VPAP; ResMed Corp., San Diego, CA, USA) in spontaneous timed (ST) mode, with an expiratory positive airway pressure (EPAP) of 7 cm H 2 O, an inspiratory positive airway pressure (IPAP) of 16 cm H 2 O, and a pressure support of 9 cm H 2 O. In May 2015, the built-in ventilator software (ResScan) reported an AHI of 5.7/hour. Duration of ventilator use was 5 hours 18 minutes. During nocturnal NPPV, mean transcutaneous carbon dioxide (PtcCO 2 ) was 45 mmhg and mean oxygen saturation was 95%, indicating resolution of the hypoventilation. Diurnal ABG analysis confirmed this finding (PaO 2,87mmHg;PaCO 2,43 mmhg; and ph, 7.45). Polysomnography (Medatec; Ablis, France) during NPPV was performed in December 2015 because our patient reported sleeping poorly. The results showed excellent upper airway patency (AHI, 1/hour); periodic limb movements with an index of 16.9/hour, resulting in sleep fragmentation with a microarousal/arousal index of 15/hour; and a mean oxygen saturation of 92.2%. In late December 2015, shortly after the polysomnography, she reported worsening exertional dyspnea. ABG analysis was performed to assess this symptom and as part of the routine monitoring of alveolar hypoventilation. Her hypoxemia had worsened (PaO 2, 53.7 mmhg), whereas PaCO 2 and ph were normal (42.8 mmhg and 7.43 respectively). She was admitted with transient nasal oxygenotherapy. Computed tomography pulmonary angiography showed dilatation of her pulmonary artery with no evidence of pulmonary embolism. During salinecontrast transthoracic echocardiography with and without Valsalva maneuvers, early passage of over 30 bubbles into the left side of her heart was noted, suggesting PFO (Fig. 2).

de Picciotto et al. Journal of Medical Case Reports (2017) 11:234 Page 3 of 5 Fig. 1 a Respiratory polygraphy. Top: Obstructive apneas are shown by solid red bars, central apneas by solid gray bars, obstructive hypopneas by red speckled bars, and indeterminate hypopneas by orange speckled bars. The height of the bars reflects the duration of the respiratory event. Bottom: Oxygen saturation by pulse oximetry. b Data from the ResMed ventilator software ResScan: obstructive apneas are in red and obstructive hypopneas in blue; the numbers above the lines are event durations in seconds. SpO 2 oxygen saturation by pulse oximetry Fig. 2 Contrast-enhanced transthoracic echocardiography. Passage of microbubbles to the left atrium during the first three beats after right atrial opacification Her left ventricular ejection fraction was normal and the estimated spap was 50 mmhg. Nasal oxygenotherapy was stopped after the diagnosis of PFO and she was monitored in the hospital for a few days, during which her pulse oximetry values improved, suggesting intermittent opening of the foramen ovale. In January 2016, spap value was again estimated at 50 mmhg, confirming the diagnosis of PH, which was ascribed to left-sided heart disease. The finding by computed tomography of smooth septal thickening in a perihilar and gravitational distribution prompted a diuretic challenge. After the treatment, transthoracic echocardiography showed normal spap (35 mmhg) and left ventricular ejection fraction, confirming the diagnosis of pulmonary edema. Given the right-to-left shunt through a PFO, the NPPV parameters were changed in January 2016: the EPAP was decreased to 6 cm H 2 OandtheIPAPto 12 cm H 2 O. In August 2016, the ventilator software reported a normal AHI of 3.4/hour (Fig. 1b) and ABG showed a mild hypercapnia and no hypoxemia (PaO 2, 85 mmhg and PaCO 2, 45.7 mmhg). These blood gas values have remained unchanged for several months (Table 1).

de Picciotto et al. Journal of Medical Case Reports (2017) 11:234 Page 4 of 5 Table 1 Time-course of arterial blood gas values and expiratory/inspiratory positive airway pressures used for noninvasive positive pressure ventilation PaO 2 mmhg PaCO 2 mmhg Hemoglobin oxygen saturation % NPPV Duration of NPPV use EPAP cm H 2 O IPAP cm H 2 O AHI January 2015 78.4 48 95.5 0 / / / 37 May 2015 87 43 97 + 5 hours 18 minutes 7 16 5.7 December 2015 53.7 42.8 90 + 3 hours 30 minutes 7 16 5 August 2016 85 45.7 96.7 + 4 hours 39 minutes 6 12 3.4 AHI apnea/hypopnea index, EPAP expiratory positive airway pressure, IPAP inspiratory positive airway pressure, NPPV noninvasive positive pressure ventilation, PaCO 2 carbon dioxide pressure in the systemic arterial blood, PaO 2 oxygen pressure in the systemic arterial blood Discussion That mechanical ventilation with PEEP can induce or worsen a right-to-left shunt through a PFO is well documented [4, 5]. In contrast, to the best of our knowledge, a single study has assessed the hemodynamic effects of noninvasive ventilation in patients with OHS, and it had only 30 patients [9]. Right ventricular overload was found in 43.3% of patients, that is, slightly above the 20 to 40% prevalence of PH reported in isolated OSAS [10, 11]. After 6 months of NPPV, there was a significant decrease in spap [9]. This result requires confirmation in larger studies. In our patient, OHS and OSAS may have contributed to the PH. The spap decline induced by diuretic therapy suggests left-sided heart disease. The mechanism by which PH secondary to left-sided heart disease may have contributed to induce right-to-left shunt through the PFO, leading to a paradoxical aggravation of the hypoxemia, remains unknown. In a patient who had OHS and OSAS with a history of unsuccessful NPPV, closure of the PFO dramatically improved the hypoxemic respiratory failure [12]. In our patient, NPPV probably further increased the right atrial pressure, reversing the pressure gradient between the two atria and inducing right-to-left shunt through the PFO. Furthermore, the PaO 2 fluctuations during NPPV treatment in our patient were consistent with intermittent opening of the foramen ovale suggesting that the balance of pressures between the right side and the left side of her heart was very unsteady. It would have been interesting to perform sequential bubble tests in increasing EPAP and IPAP values (under adequate monitoring in an intensive care unit; ICU) to provide definite proof of our hypothesis, but we did not carry out this test because of ethical considerations. Conclusion In conclusion, NPPV therapy for combined OSAS and OHS requires ABG monitoring both to evaluate the course of the hypercapnia and to look for paradoxical worsening of the hypoxemia due to right-to-left shunt through a PFO, particularly as very high pressures may be needed to correct the hypoventilation. Abbreviations ABG: Arterial blood gas; AHI: Apnea/hypopnea index; COPD: Chronic obstructive pulmonary disease; CPAP: Continuous positive airway pressure; DLCO: Diffusing capacity of the lungs for carbon monoxide; EPAP: Expiratory positive airway pressure; FEV1/VC: Forced expiratory volume in one second/ vital capacity; ICU: Intensive care unit; IPAP: Inspiratory positive airway pressure; NPPV: Noninvasive positive pressure ventilation; OHS: Obesity hypoventilation syndrome; OSAS: Obstructive sleep apnea syndrome; PaCO 2 : Carbon dioxide pressure in the systemic arterial blood; PaO 2 : Oxygen pressure in the systemic arterial blood; PEEP: Positive end-expiratory pressure; PFO: Patent foramen ovale; PH: Pulmonary hypertension; PtcCO 2 : Transcutaneous carbon dioxide; spap: Systolic pulmonary artery pressure; ST: Spontaneous timed; TEE: Transesophageal echocardiography Acknowledgements We thank the patient who generously provided consent to publish her medical history to help other patients. Funding There was no funding for writing this article. Availability of data and materials All data are available in the electronic medical records of our hospital, accessible to the treating medical doctors. Authors contributions CdP, CD, VG, and MB analyzed and interpreted the patient data regarding the respiratory disease. OA analyzed and interpreted the patient data regarding the cardiovascular disease. CdP and MB were major contributors in writing the manuscript. All authors read and approved the final manuscript. Ethics approval and consent to participate Not applicable. Consent for publication Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests The authors declare that they have no competing interests. Publisher s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Author details 1 Service de Physiologie-Explorations Fonctionnelles, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France. 2 Service de Pneumologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France. 3 Service de Cardiologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne, France. 4 Unité Inserm U1179, laboratoire de physiologie TITAN, UFR des Sciences de la Santé Simone Veil, Université de Versailles St Quentin (UVSQ), Montigny le Bretonneux, France. 5 Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92104 Boulogne cedex, France.

de Picciotto et al. Journal of Medical Case Reports (2017) 11:234 Page 5 of 5 Received: 5 April 2017 Accepted: 19 July 2017 References 1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life; an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17 20. 2. Bancal C, Arnoult F, Krapf L, Bonay M. Patent foramen ovale and hypoxaemia with or without elevated right heart pressures. Rev Mal Respir. 2011;28:967 77. 3. Shanoudy H, Soliman A, Raggi P, Liu JW, Russell DC, Jarmukli NF. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest. 1998;113:91 6. 4. Cujec B, Polasek P, Mayers I, Johnson D. Positive end-expiratory pressure increases the right-to-left shunt in mechanically ventilated patients with patent foramen ovale. Ann Intern Med. 1993;119:887 94. 5. Pick RA, Handler JB, Murata GH, Friedman AS. The cardiovascular effect of positive end-expiratory pressure. Chest. 1982;82:345 50. 6. Lemaire F, Richalet JP, Carlet J, Brun-Buisson C, MacLean C. Postoperative hypoxemia due to opening of a patent foramen ovale confirmed by a right atrium-left atrium pressure gradient during mechanical ventilation. Anesthesiology. 1982;57:233 6. 7. Konstadt SN, Louie EK, Black S, Rao TL, Scanlon P. Intraoperative detection of patent foramen ovale by transesophageal echocardiography. Anesthesiology. 1991;74:212 6. 8. Jullien V, Benhamou M, Lanfranchi P, Perrin C. Increase in right-to-left intracardiac shunt with non-invasive ventilation. Rev Mal Respir. 2005; 22:321 3. 9. Castro-Añón O, Golpe R, Pérez-de-Llano LA, López González MJ, Escalona Velasquez EJ, Pérez FR. Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome. Respirology. 2012;17:1269 74. 10. Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban JP. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934 9. 11. Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Douglas MR. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518 26. 12. Mehrotra AK, Cork DP, Weiss SA, Shah AP. Dramatic improvement in hypoxemic respiratory failure after patent foramen ovale closure in a patient with obesity hypoventilation syndrome. Cardiovasc Revasc Med. 2012;13:295 7. Submit your next manuscript to BioMed Central and we will help you at every step: We accept pre-submission inquiries Our selector tool helps you to find the most relevant journal We provide round the clock customer support Convenient online submission Thorough peer review Inclusion in PubMed and all major indexing services Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submit